Skip to main content
SpringerLink
Log in

Nutraceuticals Supporting Body Weight Loss

  • Chapter
  • First Online:
Nutraceuticals and Cardiovascular Disease

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 362 Accesses

Abstract

It is known that obesity has reached epidemic proportions and its management is of high clinical importance. In this chapter we will discuss recent data about the role of nutraceuticals and functional foods in obesity and body weight management, including the mechanisms responsible for their favorable effects. In addition, the impact of healthy dietary patterns on weight loss will be addressed. Apart from influencing the imbalance between energy intake and output, nutraceuticals may prevent and/or decrease the development of oxidative stress and inflammation in obesity, as well as favorably influence other cardiovascular disease risk factors, thereby limiting obesity-related complications. A place for nutraceuticals in daily clinical practice is emerging, but the current evidence supporting their use is still limited. Further research will lead to the development of novel nutraceuticals/functional foods/dietary patterns to successfully prevent and/or combat obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Martin-Rodriguez E, Guillen-Grima F, Marti A, Brugos-Larumbe A. Comorbidity associated with obesity in a large population: the APNA study. Obes Res Clin Pract. 2015;9:435–47.

    Article  PubMed  Google Scholar 

  2. Global BMIMC, Di Angelantonio E, Bhupathiraju Sh N, Wormser D, Gao P, Kaptoge S, et al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776–86.

    Article  Google Scholar 

  3. World Health Organization. Obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

  4. NHLBI Obesity education initiative expert panel on the identification, evaluation, and treatment of obesity in adults (US). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda (MD): National Heart, Lung, and Blood Institute; 1998 Sep.. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2003/

  5. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014;63:2985–3023.

    Article  PubMed  Google Scholar 

  6. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203.

    Article  PubMed  Google Scholar 

  7. Valsamakis G, Konstantakou P, Mastorakos G. New targets for drug treatment of obesity. Annu Rev Pharmacol Toxicol. 2017;57:585–605.

    Article  CAS  PubMed  Google Scholar 

  8. Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA. Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity (Silver Spring). 2008;16:790–6.

    Article  CAS  Google Scholar 

  9. Dikeman CL, Murphy MR, Fahey GC Jr. Dietary fibers affect viscosity of solutions and simulated human gastric and small intestinal digesta. J Nutr. 2006;136:913–9.

    Article  CAS  PubMed  Google Scholar 

  10. Howarth NC, Saltzman E, Roberts SB. Dietary fiber and weight regulation. Nutr Rev. 2001;59:129–39.

    Article  CAS  PubMed  Google Scholar 

  11. Wanders AJ, van den Borne JJ, de Graaf C, Hulshof T, Jonathan MC, Kristensen M, et al. Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials. Obes Rev. 2011;12:724–39.

    CAS  PubMed  Google Scholar 

  12. Du H, van der Daphne A, Boshuizen HC, Forouhi NG, Wareham NJ, Halkjaer J, et al. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. Am J Clin Nutr. 2010;91:329–36.

    Article  CAS  PubMed  Google Scholar 

  13. Lairon D. Dietary fiber and control of body weight. Nutr Metab Cardiovasc Dis. 2007;17:1–5.

    Article  PubMed  Google Scholar 

  14. Slavin JL. Dietary fiber and body weight. Nutrition. 2005;21:411–8.

    Article  PubMed  Google Scholar 

  15. Thompson SV, Hannon BA, An R, Holscher HD. Effects of isolated soluble fiber supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2017;106:1514–28.

    Article  CAS  PubMed  Google Scholar 

  16. Pal S, McKay J, Jane M, Ho S. Chapter 19 – Using psyllium to prevent and treat obesity comorbidities. Nutrition in the prevention and treatment of abdominal obesity. 2nd ed. 2019. p. 245–260.

    Google Scholar 

  17. Masood R, Miraftab M. Psyllium: current and future applications. Medical and Healthcare Textiles 2010. p. 244-253.

    Google Scholar 

  18. Dahiya DK, Renuka, Puniya M, Shandilya UK, Dhewa T, Kumar N, et al. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: a review. Front Microbiol. 2017;8:563.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Darooghegi Mofrad M, Mozaffari H, Mousavi SM, Sheikhi A, Milajerdi A. The effects of psyllium supplementation on body weight, body mass index and waist circumference in adults: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;60:859–72.

    Article  PubMed  Google Scholar 

  20. Pal S, Radavelli-Bagatini S. Effects of psyllium on metabolic syndrome risk factors. Obes Rev. 2012;13:1034–47.

    Article  CAS  PubMed  Google Scholar 

  21. Ziai SA, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F, et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005;102:202–7.

    Article  CAS  PubMed  Google Scholar 

  22. Kris-Etherton PM, Taylor DS, Smiciklas-Wright H, Mitchell DC, Bekhuis TC, Olson BH, et al. High-soluble-fiber foods in conjunction with a telephone-based, personalized behavior change support service result in favorable changes in lipids and lifestyles after 7 weeks. J Am Diet Assoc. 2002;102:503–10.

    Article  PubMed  Google Scholar 

  23. Pal S, Ho S, Gahler RJ, Wood S. Effect on body weight and composition in overweight/obese Australian adults over 12 months consumption of two different types of fibre supplementation in a randomized trial. Nutr Metab (Lond). 2016;13:82.

    Article  Google Scholar 

  24. Jane M, McKay J, Pal S. Effects of daily consumption of psyllium, oat bran and polyGlycopleX on obesity-related disease risk factors: a critical review. Nutrition. 2019;57:84–91.

    Article  CAS  PubMed  Google Scholar 

  25. Khan K, Jovanovski E, Ho HVT, Marques ACR, Zurbau A, Mejia SB, et al. The effect of viscous soluble fiber on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2018;28:3–13.

    Article  CAS  PubMed  Google Scholar 

  26. Bernstein AM, Titgemeier B, Kirkpatrick K, Golubic M, Roizen MF. Major cereal grain fibers and psyllium in relation to cardiovascular health. Nutrients. 2013;5:1471–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Xiao Z, Chen H, Zhang Y, Deng H, Wang K, Bhagavathula AS, et al. The effect of psyllium consumption on weight, body mass index, lipid profile, and glucose metabolism in diabetic patients: a systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2020;34:1237–47.

    Article  CAS  PubMed  Google Scholar 

  28. Whitehead A, Beck EJ, Tosh S, Wolever TM. Cholesterol-lowering effects of oat beta-glucan: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2014;100:1413–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Lazaridou A, Biliaderis CG. Molecular aspects of cereal β-glucan functionality: physical properties, technological applications and physiological effects. J Cereal Sci. 2007;46:101–18.

    Article  CAS  Google Scholar 

  30. Ho HV, Sievenpiper JL, Zurbau A, Blanco Mejia S, Jovanovski E, Au-Yeung F, et al. The effect of oat beta-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials. Br J Nutr. 2016;116:1369–82.

    Article  CAS  PubMed  Google Scholar 

  31. Beck EJ, Tosh SM, Batterham MJ, Tapsell LC, Huang XF. Oat beta-glucan increases postprandial cholecystokinin levels, decreases insulin response and extends subjective satiety in overweight subjects. Mol Nutr Food Res. 2009;53:1343–51.

    Article  CAS  PubMed  Google Scholar 

  32. Beck EJ, Tapsell LC, Batterham MJ, Tosh SM, Huang XF. Oat beta-glucan supplementation does not enhance the effectiveness of an energy-restricted diet in overweight women. Br J Nutr. 2010;103:1212–22.

    Article  CAS  PubMed  Google Scholar 

  33. Kabir M, Oppert JM, Vidal H, Bruzzo F, Fiquet C, Wursch P, et al. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism. 2002;51:819–26.

    Article  CAS  PubMed  Google Scholar 

  34. Maki KC, Galant R, Samuel P, Tesser J, Witchger MS, Ribaya-Mercado JD, et al. Effects of consuming foods containing oat beta-glucan on blood pressure, carbohydrate metabolism and biomarkers of oxidative stress in men and women with elevated blood pressure. Eur J Clin Nutr. 2007;61:786–95.

    Article  CAS  PubMed  Google Scholar 

  35. Queenan KM, Stewart ML, Smith KN, Thomas W, Fulcher RG, Slavin JL. Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J. 2007;6:6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Rahmani J, Miri A, Cerneviciute R, Thompson J, de Souza NN, Sultana R, et al. Effects of cereal beta-glucan consumption on body weight, body mass index, waist circumference and total energy intake: a meta-analysis of randomized controlled trials. Complement Ther Med. 2019;43:131–9.

    Article  PubMed  Google Scholar 

  37. Muanprasat C, Chatsudthipong V. Chitosan oligosaccharide: biological activities and potential therapeutic applications. Pharmacol Ther. 2017;170:80–97.

    Article  CAS  PubMed  Google Scholar 

  38. van Bennekum AM, Nguyen DV, Schulthess G, Hauser H, Phillips MC. Mechanisms of cholesterol-lowering effects of dietary insoluble fibres: relationships with intestinal and hepatic cholesterol parameters. Br J Nutr. 2005;94:331–7.

    Article  PubMed  CAS  Google Scholar 

  39. Rios-Hoyo A, Gutierrez-Salmean G. New dietary supplements for obesity: what we currently know. Curr Obes Rep. 2016;5:262–70.

    Article  PubMed  Google Scholar 

  40. Barrea L, Altieri B, Polese B, De Conno B, Muscogiuri G, Colao A, et al. Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements. Int J Obes Suppl. 2019;9:32–49.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Tang D, Wang Y, Kang W, Zhou J, Dong R, Feng Q. Chitosan attenuates obesity by modifying the intestinal microbiota and increasing serum leptin levels in mice. J Funct Foods. 2020;64:103659.

    Article  CAS  Google Scholar 

  42. Huang H, Liao D, Zou Y, Chi H. The effects of chitosan supplementation on body weight and body composition: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019:1–11.

    Google Scholar 

  43. Moraru C, Mincea MM, Frandes M, Timar B, Ostafe V. A meta-analysis on randomised controlled clinical trials evaluating the effect of the dietary supplement chitosan on weight loss, lipid parameters and blood pressure. Medicina (Kaunas). 2018;54

    Google Scholar 

  44. Jull AB, Ni Mhurchu C, Bennett DA, Dunshea-Mooij CA, Rodgers A. Chitosan for overweight or obesity. Cochrane Database Syst Rev. 2008:CD003892.

    Google Scholar 

  45. EFSA Panel on Dietetic Products N, Allergies. Scientific Opinion on the substantiation of health claims related to chitosan and reduction in body weight (ID 679, 1499), maintenance of normal blood LDL-cholesterol concentrations (ID 4663), reduction of intestinal transit time (ID 4664) and reduction of inflammation (ID 1985) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. 2011; 9: 2214.

    Google Scholar 

  46. Han Y, Zhang L, Liu XQ, Zhao ZJ, Lv LX. Effect of glucomannan on functional constipation in children: a systematic review and meta-analysis of randomised controlled trials. Asia Pac J Clin Nutr. 2017;26:471–7.

    PubMed  Google Scholar 

  47. Janani F, Changaee F. The effect of glucomannan on pregnancy constipation. J Family Med Prim Care. 2018;7:903–6.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Zalewski BM, Chmielewska A, Szajewska H. The effect of glucomannan on body weight in overweight or obese children and adults: a systematic review of randomized controlled trials. Nutrition. 2015;31:437–42. e2

    Article  CAS  PubMed  Google Scholar 

  49. Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr. 2008;88:1167–75.

    Article  CAS  PubMed  Google Scholar 

  50. Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2014;33:70–8.

    Article  CAS  PubMed  Google Scholar 

  51. Solah VA, Kerr DA, Hunt WJ, Johnson SK, Boushey CJ, Delp EJ, et al. Effect of fibre supplementation on body weight and composition, frequency of eating and dietary choice in overweight individuals. Nutrients. 2017;9

    Google Scholar 

  52. Ross SM. African mango (IGOB131): a proprietary seed extract of Irvingia gabonensis is found to be effective in reducing body weight and improving metabolic parameters in overweight humans. Holist Nurs Pract. 2011;25:215–7.

    Article  PubMed  Google Scholar 

  53. Ngondi JL, Oben JE, Minka SR. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids Health Dis. 2005;4:12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  54. Oben JE, Ngondi JL, Momo CN, Agbor GA, Sobgui CS. The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study. Lipids Health Dis. 2008;7:12.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids Health Dis. 2009;8:7.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Lee J, Chung M, Fu Z, Choi J, Lee HJ. The effects of Irvingia gabonensis seed extract supplementation on anthropometric and cardiovascular outcomes: a systematic review and meta-analysis. J Am Coll Nutr. 2019:1–9.

    Google Scholar 

  57. Gammone MA, D’Orazio N. Anti-obesity activity of the marine carotenoid fucoxanthin. Mar Drugs. 2015;13:2196–214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Abidov M, Ramazanov Z, Seifulla R, Grachev S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes Metab. 2010;12:72–81.

    Article  CAS  PubMed  Google Scholar 

  59. Guo B, Yang B, Pang X, Chen T, Chen F, Cheng KW. Fucoxanthin modulates cecal and fecal microbiota differently based on diet. Food Funct. 2019;10:5644–55.

    Article  CAS  PubMed  Google Scholar 

  60. Haber SL, Awwad O, Phillips A, Park AE, Pham TM. Garcinia cambogia for weight loss. Am J Health Syst Pharm. 2018;75:17–22.

    Article  PubMed  Google Scholar 

  61. Maia-Landim A, Ramirez JM, Lancho C, Poblador MS, Lancho JL. Long-term effects of Garcinia cambogia/Glucomannan on weight loss in people with obesity, PLIN4, FTO and Trp64Arg polymorphisms. BMC Complement Altern Med. 2018;18:26.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  62. Pekala J, Patkowska-Sokola B, Bodkowski R, Jamroz D, Nowakowski P, Lochynski S, et al. L-carnitine--metabolic functions and meaning in humans life. Curr Drug Metab. 2011;12:667–78.

    Article  CAS  PubMed  Google Scholar 

  63. Nazari M, Saberi A, Karandish M, Neisi N, Jalali MT, Makvandi M. Influence of L-carnitine on the expression level of adipose tissue miRNAs related to weight changes in obese rats. Pak J Biol Sci. 2016;19:227–32.

    Article  CAS  PubMed  Google Scholar 

  64. Karlic H, Lohninger A. Supplementation of L-carnitine in athletes: does it make sense? Nutrition. 2004;20:709–15.

    Article  CAS  PubMed  Google Scholar 

  65. Pooyandjoo M, Nouhi M, Shab-Bidar S, Djafarian K, Olyaeemanesh A. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2016;17:970–6.

    Article  CAS  PubMed  Google Scholar 

  66. Hursel R, Viechtbauer W, Westerterp-Plantenga MS. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes. 2009;33:956–61.

    Article  CAS  Google Scholar 

  67. Lin JK, Lin CL, Liang YC, Lin-Shiau SY, Juan IM. Survey of catechins, gallic acid, and methylxanthines in green, oolong, pu-erh, and black teas. J Agric Food Chem. 1998;46:3635–42.

    Article  CAS  Google Scholar 

  68. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010;5:13.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Wolfram S, Wang Y, Thielecke F. Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res. 2006;50:176–87.

    Article  CAS  PubMed  Google Scholar 

  70. Grove KA, Sae-tan S, Kennett MJ, Lambert JD. (−)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity. 2012;20:2311–3.

    Article  CAS  PubMed  Google Scholar 

  71. Venkatakrishnan K, Chiu HF, Wang CK. Extensive review of popular functional foods and nutraceuticals against obesity and its related complications with a special focus on randomized clinical trials. Food Funct. 2019;10:2313–29.

    Article  CAS  PubMed  Google Scholar 

  72. Chen IJ, Liu CY, Chiu JP, Hsu CH. Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr. 2016;35:592–9.

    Article  CAS  PubMed  Google Scholar 

  73. Zhang X, Zhang M, Ho CT, Guo X, Wu Z, Weng P, et al. Metagenomics analysis of gut microbiota modulatory effect of green tea polyphenols by high fat diet-induced obesity mice model. J Funct Foods. 2018;46:268–77.

    Article  CAS  Google Scholar 

  74. Lin Y, Shi D, Su B, Wei J, Gaman MA, Sedanur Macit M, et al. The effect of green tea supplementation on obesity: a systematic review and dose-response meta-analysis of randomized controlled trials. Phytother Res. 2020;

    Google Scholar 

  75. Li X, Wang W, Hou L, Wu H, Wu Y, Xu R, et al. Does tea extract supplementation benefit metabolic syndrome and obesity? A systematic review and meta-analysis. Clin Nutr. 2020;39:1049–58.

    Article  CAS  PubMed  Google Scholar 

  76. Jurgens TM, Whelan AM, Killian L, Doucette S, Kirk S, Foy E. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev. 2012;

    Google Scholar 

  77. Smith C, Krygsman A. Hoodia gordonii: to eat, or not to eat. J Ethnopharmacol. 2014;155:987–91.

    Article  PubMed  Google Scholar 

  78. Blom WA, Abrahamse SL, Bradford R, Duchateau GS, Theis W, Orsi A, et al. Effects of 15-d repeated consumption of Hoodia gordonii purified extract on safety, ad libitum energy intake, and body weight in healthy, overweight women: a randomized controlled trial. Am J Clin Nutr. 2011;94:1171–81.

    Article  CAS  PubMed  Google Scholar 

  79. Landor M, Benami A, Segev N, Loberant B. Efficacy and acceptance of a commercial Hoodia parviflora product for support of appetite and weight control in a consumer trial. J Med Food. 2015;18:250–8.

    Article  PubMed  Google Scholar 

  80. Perna S, Infantino V, Peroni G, Gasparri C, Faliva MA, Naso M, et al. Effects of Hoodia Parviflora on satiety, abdominal obesity and weight in a group of overweight subjects: a randomized, blinded, placebo-controlled trial. Minerva Gastroenterol Dietol. 2020;

    Google Scholar 

  81. Onakpoya I, Hunt K, Wider B, Ernst E. Pyruvate supplementation for weight loss: a systematic review and meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr. 2014;54:17–23.

    Article  CAS  PubMed  Google Scholar 

  82. Ostojic SM, Ahmetovic Z. The effect of 4 weeks treatment with a 2-gram daily dose of pyruvate on body composition in healthy trained men. Int J Vitam Nutr Res. 2009;79:173–9.

    Article  CAS  PubMed  Google Scholar 

  83. Icken D, Feller S, Engeli S, Mayr A, Muller A, Hilbert A, et al. Caffeine intake is related to successful weight loss maintenance. Eur J Clin Nutr. 2016;70:532–4.

    Article  CAS  PubMed  Google Scholar 

  84. Tabrizi R, Saneei P, Lankarani KB, Akbari M, Kolahdooz F, Esmaillzadeh A, et al. The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2019;59:2688–96.

    Article  CAS  PubMed  Google Scholar 

  85. Stohs SJ. Safety, efficacy, and mechanistic studies regarding Citrus aurantium (bitter orange) extract and p-Synephrine. Phytother Res. 2017;31:1463–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Capomolla AS, Janda E, Paone S, Parafati M, Sawicki T, Mollace R, et al. Atherogenic index reduction and weight loss in metabolic syndrome patients treated with a novel pectin-enriched formulation of bergamot polyphenols. Nutrients. 2019;11

    Google Scholar 

  87. Ribeiro C, Dourado G, Cesar T. Orange juice allied to a reduced-calorie diet results in weight loss and ameliorates obesity-related biomarkers: a randomized controlled trial. Nutrition. 2017;38:13–9.

    Article  CAS  PubMed  Google Scholar 

  88. Albarracin CA, Fuqua BC, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev. 2008;24:41–51.

    Article  CAS  PubMed  Google Scholar 

  89. Frauchiger MT, Wenk C, Colombani PC. Effects of acute chromium supplementation on postprandial metabolism in healthy young men. J Am Coll Nutr. 2004;23:351–7.

    Article  CAS  PubMed  Google Scholar 

  90. Hoffman JR, Kang J, Ratamess NA, Jennings PF, Mangine G, Faigenbaum AD. Thermogenic effect from nutritionally enriched coffee consumption. J Int Soc Sports Nutr. 2006;3:35–41.

    Article  PubMed  PubMed Central  Google Scholar 

  91. National Institutes of HealthDietary Supplement Fact Sheet: Chromium Bethesda, MD: Office of Dietary Supplements, NIH ClinicalCenter, National Institutes of Health. 2007.

    Google Scholar 

  92. Tsang C, Taghizadeh M, Aghabagheri E, Asemi Z, Jafarnejad S. A meta-analysis of the effect of chromium supplementation on anthropometric indices of subjects with overweight or obesity. Clin Obes. 2019;9:e12313.

    Article  PubMed  Google Scholar 

  93. Onakpoya I, Posadzki P, Ernst E. Chromium supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. Obes Rev. 2013;14:496–507.

    Article  CAS  PubMed  Google Scholar 

  94. den Hartigh LJ. Conjugated linoleic acid effects on cancer, obesity, and atherosclerosis: a review of pre-clinical and human trials with current perspectives. Nutrients. 2019;11

    Google Scholar 

  95. Riserus U, Smedman A, Basu S, Vessby B. CLA and body weight regulation in humans. Lipids. 2003;38:133–7.

    Article  CAS  PubMed  Google Scholar 

  96. Esmaeili Shahmirzadi F, Ghavamzadeh S, Zamani T. The effect of conjugated linoleic acid supplementation on body composition, serum insulin and leptin in obese adults. Arch Iran Med. 2019;22:255–61.

    PubMed  Google Scholar 

  97. Madry E, Chudzicka-Strugala I, Grabanska-Martynska K, Malikowska K, Grebowiec P, Lisowska A, et al. Twelve weeks CLA supplementation decreases the hip circumference in overweight and obese women. A double-blind, randomized, placebo-controlled trial. Acta Sci Pol Technol Aliment. 2016;15:107–13.

    Article  PubMed  Google Scholar 

  98. Belury MA, Mahon A, Banni S. The conjugated linoleic acid (CLA) isomer, t10c12-CLA, is inversely associated with changes in body weight and serum leptin in subjects with type 2 diabetes mellitus. J Nutr. 2003;133:257S–60S.

    Article  PubMed  Google Scholar 

  99. Namazi N, Irandoost P, Larijani B, Azadbakht L. The effects of supplementation with conjugated linoleic acid on anthropometric indices and body composition in overweight and obese subjects: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2019;59:2720–33.

    Article  CAS  PubMed  Google Scholar 

  100. Suzuki S, Nishijima C, Sato Y, Umegaki K, Murata M, Chiba T. Coleus forskohlii extract attenuated the beneficial effect of diet-treatment on NASH in mouse model. J Nutr Sci Vitaminol (Tokyo). 2020;66:191–9.

    Article  CAS  Google Scholar 

  101. Loftus HL, Astell KJ, Mathai ML, Su XQ. Coleus forskohlii extract supplementation in conjunction with a Hypocaloric diet reduces the risk factors of metabolic syndrome in overweight and obese subjects: a randomized controlled trial. Nutrients. 2015;7:9508–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Henderson S, Magu B, Rasmussen C, Lancaster S, Kerksick C, Smith P, et al. Effects of coleus forskohlii supplementation on body composition and hematological profiles in mildly overweight women. J Int Soc Sports Nutr. 2005;2:54–62.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Heredia-Rodríguez L, de la Garza AL, Garza-Juarez AJ, Vazquez-Rodriguez JA. Nutraceutical properties of bioactive peptides in common bean (Phaseolus vulgaris L.). J Food Nutri Diete. 2016;2:111.

    Google Scholar 

  104. Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011;10:24.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Udani J, Tan O, Molina J. Systematic review and meta-analysis of a proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris L.) on weight and fat loss in humans. Foods. 2018:7.

    Google Scholar 

  106. Nolan R, Shannon OM, Robinson N, Joel A, Houghton D, Malcomson FC. It’s no has bean: a review of the effects of white kidney bean extract on body composition and metabolic health. Nutrients. 2020;12

    Google Scholar 

  107. Støa Birketvedt G, Langbakk B, Florholmen J. A dietary supplement with bean extract decreases body weight, body fat, waist circumference and blood pressure in over-weight and obese subjects. Curr Top Nutraceutical Res. 2005;3:137–42.

    Google Scholar 

  108. Udani J, Hardy M, Madsen DC. Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev. 2004;9:63–9.

    PubMed  Google Scholar 

  109. Udani J, Singh BB. Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med. 2007;13:32–7.

    PubMed  Google Scholar 

  110. Davis CD. The gut microbiome and its role in obesity. Nutr Today. 2016;51:167–74.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Delzenne NM, Neyrinck AM, Backhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol. 2011;7:639–46.

    Article  CAS  PubMed  Google Scholar 

  112. Boulange CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8:42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  113. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506–14.

    Article  PubMed  Google Scholar 

  114. George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, Das G. Benefaction of probiotics for human health: a review. J Food Drug Anal. 2018;26:927–39.

    Article  CAS  PubMed  Google Scholar 

  115. Ctoi AF, Corina A, Katsiki N, Vodnar DC, Andreicut AD, Stoian AP, et al. Gut microbiota and aging – a focus on centenarians. Biochim Biophys Acta Mol basis Dis. 1866;2020:165765.

    Google Scholar 

  116. Hunter PM, Hegele RA. Functional foods and dietary supplements for the management of dyslipidaemia. Nat Rev Endocrinol. 2017;13:278–88.

    Article  CAS  PubMed  Google Scholar 

  117. Suzumura EA, Bersch-Ferreira AC, Torreglosa CR, da Silva JT, Coqueiro AY, Kuntz MGF, et al. Effects of oral supplementation with probiotics or synbiotics in overweight and obese adults: a systematic review and meta-analyses of randomized trials. Nutr Rev. 2019;77:430–50.

    Article  PubMed  Google Scholar 

  118. Ejtahed HS, Angoorani P, Soroush AR, Atlasi R, Hasani-Ranjbar S, Mortazavian AM, et al. Probiotics supplementation for the obesity management; a systematic review of animal studies and clinical trials. J Funct Foods. 2019;52:228–42.

    Article  CAS  Google Scholar 

  119. Park S, Bae JH. Probiotics for weight loss: a systematic review and meta-analysis. Nutr Res. 2015;35:566–75.

    Article  CAS  PubMed  Google Scholar 

  120. Zhang Q, Wu Y, Fei X. Effect of probiotics on body weight and body-mass index: a systematic review and meta-analysis of randomized, controlled trials. Int J Food Sci Nutr. 2015;67:571–80.

    Article  PubMed  Google Scholar 

  121. Taghizadeh M, Farzin N, Taheri S, Mahlouji M, Akbari H, Karamali F, et al. The effect of dietary supplements containing green tea, capsaicin and ginger extracts on weight loss and metabolic profiles in overweight women: a randomized double-blind placebo-controlled clinical trial. Ann Nutr Metab. 2017;70:277–85.

    Article  CAS  PubMed  Google Scholar 

  122. Salvia R, D’Amore S, Graziano G, Capobianco C, Sangineto M, Paparella D, et al. Short-term benefits of an unrestricted-calorie traditional Mediterranean diet, modified with a reduced consumption of carbohydrates at evening, in overweight-obese patients. Int J Food Sci Nutr. 2017;68:234–48.

    Article  CAS  PubMed  Google Scholar 

  123. Nordmann AJ, Suter-Zimmermann K, Bucher HC, Shai I, Tuttle KR, Estruch R, et al. Meta-analysis comparing Mediterranean to low-fat diets for modification of cardiovascular risk factors. Am J Med. 2011;124:841–51. e2

    Article  PubMed  Google Scholar 

  124. Vitale M, Masulli M, Calabrese I, Rivellese AA, Bonora E, Signorini S, et al. Impact of a Mediterranean dietary pattern and its components on cardiovascular risk factors, glucose control, and body weight in people with type 2 diabetes: a real-life study. Nutrients. 2018;10

    Google Scholar 

  125. Jenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, et al. Effect of a 6-month vegan low-carbohydrate (‘Eco-Atkins’) diet on cardiovascular risk factors and body weight in hyperlipidaemic adults: a randomised controlled trial. BMJ Open. 2014;4:e003505.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Mansoor N, Vinknes KJ, Veierod MB, Retterstol K. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br J Nutr. 2016;115:466–79.

    Article  CAS  PubMed  Google Scholar 

  127. Lopez HL, Ziegenfuss TN, Hofheins JE, Habowski SM, Arent SM, Weir JP, et al. Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women. J Int Soc Sports Nutr. 2013;10:22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Liu Y, Cotillard A, Vatier C, Bastard JP, Fellahi S, Stevant M, et al. A dietary supplement containing cinnamon, chromium and Carnosine decreases fasting plasma glucose and increases lean mass in overweight or obese pre-diabetic subjects: a randomized, placebo-controlled trial. PLoS One. 2015;10:e0138646.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lipid and Atherosclerosis Unit, IMIBIC/Reina Sofia University Hospital/University of Cordoba, Cordoba, Spain

    Andreea Corina & Pablo Perez-Martinez

  2. CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain

    Andreea Corina & Pablo Perez-Martinez

  3. PROMISE Department, School of Medicine, University of Palermo, Palermo, Italy

    Dragana Nikolic

  4. Pathophysiology Department, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania

    Adriana Florinela Cӑtoi

Authors
  1. Andreea Corina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dragana Nikolic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adriana Florinela Cӑtoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pablo Perez-Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. S. Orsola-Malpighi University Hospital, University of Bologna, BOLOGNA, Bologna, Italy

    Arrigo F.G. Cicero

  2. School of Medicine, University of Palermo, Palermo, Palermo, Italy

    Manfredi Rizzo

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Corina, A., Nikolic, D., Cӑtoi, A.F., Perez-Martinez, P. (2021). Nutraceuticals Supporting Body Weight Loss. In: Cicero, A.F., Rizzo, M. (eds) Nutraceuticals and Cardiovascular Disease. Contemporary Cardiology. Humana, Cham. https://doi.org/10.1007/978-3-030-62632-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62632-7_8

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-62631-0

  • Online ISBN: 978-3-030-62632-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation